logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
D

Daan van den Broek

department of laboratory medicine, the netherlands cancer institute, amsterdam, the netherlands
H指数:28
被引数:2,774

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

CtDNA-guided de-escalation of adjuvant chemotherapy in stage III colon cancer: early model-based evaluation of cost-effectiveness

CtDNA指导下的辅助化疗降级治疗在III期结肠癌中的应用：基于模型的早期成本效益评估

Therapeutic Advances in Medical Oncology
IF4.2
2025-11-060
OA
Haoyue Wang; Astrid Kramer; Marjolein J. E. Greuter; Carmen Rubio-Alarcón; Birgit Lissenberg-Witte; Gerrit A. Meijer; Niels F. M. Kok; Daan van den Broek; Geraldine R. Vink; Jeanine M. L. Roodhart; Mark Sausen; Remond J. A. Fijneman; Veerle M. H. Coupé
Determining the optimal approach to identify osimertinib resistance; the first line osimertinib cohort of the OSIRIS study

确定识别奥希康替尼耐药性的最佳方法；OSIRIS研究中的奥希康替尼一线治疗队列

Lung Cancer
IF4.4
2025-09-280
PRE
J.W.T. van der Wel; S.M. Ernst; M. Jebbink; D. van den Broek; S.K. Badrising; L.C. Steinbusch; G. Ruiter; W.S.M.E. Theelen; B.A.M.H. van Veggel; J. Smit; A.M. Dingemans; M.S. Paats; H.J. Dubbink; S.M.S. Hashemi; T. Radonic; D. Cohen; A.J. van der Wekken; A. ter Elst; W. Timens; L.E. Hendriks; E.J.M. Speel; M.M.J. Disselhorst; A. Welling; F. van der Meer; L.J.W. Bosch; K. Monkhorst; M.C. Boelens; E.F. Smit; A.J. de Langen
Durable responses upon short-term addition of targeted therapy to anti-PD1 in advanced melanoma patients: 5-year progression-free and overall survival update of the IMPemBra trial

短期添加靶向治疗联合抗PD1在晚期黑色素瘤患者中的持久响应：IMPemBra试验的5年无进展生存率和总生存率更新

EUROPEAN JOURNAL OF CANCER
IF7.1
2025-06-010
PRE
Hoeijmakers, L. L.; Rozeman, E. A.; Lopez-Yurda, M.; Grijpink-Ongering, L. G.; Heeres, B. C.; van de Wiel, B. A.; Flohil, C.; Sari, A.; Heijmink, S. W. T. P. J.; van den Broek, D.; Broeks, A.; de Groot, J. W. B.; Vollebergh, M. A.; Wilgenhof, S.; van Thienen, J. V.; Haanen, J. B. A. G.; Blank, C. U.
High Prevalence of Chromosomal Rearrangements and LINE Retrotranspositions Detected in Formalin-Fixed, Paraffin-Embedded Colorectal Cancer Tissue
JOURNAL OF MOLECULAR DIAGNOSTICS
IF3.4
2024-12-010
OAAI
Rubio-Alarcon, Carmen; Stelloo, Ellen; Vessies, Daan C. L.; Erve, Iris van't; Mekkes, Nienke J.; Swennenhuis, Joost; Lakbir, Soufyan; van Bree, Elisabeth J.; Tijssen, Marianne; Diemen, Pien Delis-van; Lanfermeijer, Mirthe; Linders, Theodora; van den Broek, Daan; Punt, Cornelis J. A.; Heringa, Jaap; Meijer, Gerrit A.; Abeln, Sanne; Feitsma, Harma; Fijneman, Remond J. A.
Predictive value of circulating tumor DNA (ctDNA) before and shortly after curative treatment in early stage non-small cell lung cancer (NSCLC), and exploration of (pre-)analytical factors

早期非小细胞肺癌（NSCLC）在根治性治疗前后循环肿瘤DNA（ctDNA）的预测价值，以及对（预）分析因素的探索

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
van den Heuvel, M.; Smith, C. G.; Schuurbiers, M.; Hartemink, K.; Rintoul, R.; Monkhorst, K.; Van Den Broek, D.; Rosenfeld, N.
Combined molecular analysis of circulating tumour DNA and tumour tissue to identify osimertinib resistance

结合循环肿瘤DNA和肿瘤组织的分子联合分析以识别奥希替尼耐药性

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
van der Wel, T.; Jebbink, M.; Badrising, S.; Steinbusch, L.; Ruiter, G.; Theelen, W. S. M. E.; Veggel, B. V.; Smit, J.; Hashemi, S.; Van Der Wekken, A. J.; Hendriks, L. E.; Paats, M. S.; Ernst, S.; Van Den Broek, D.; Bosch, L. J. W.; Monkhorst, K.; Smit, E. F.; Boelens, M. C.; De langen, A. J.
Early evaluation of the effectiveness and cost-effectiveness of ctDNA-guided selection for adjuvant chemotherapy in stage II colon cancer

ctDNA指导的 ⅱ 期结肠癌辅助化疗选择的有效性和成本-效果的早期评价

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
IF4.2
2024-08-212
OAAI
Kramer, Astrid; Greuter, Marjolein J. E.; Schraa, Suzanna J.; Vink, Geraldine R.; Phallen, Jillian; Velculescu, Victor E.; Meijer, Gerrit A.; van den Broek, Daan; Koopman, Miriam; Roodhart, Jeanine M. L.; Fijneman, Remond J. A.; Retel, Valesca P.; Coupe, Veerle M. H.
Clinical validity of post-surgery circulating tumor DNA testing in stage III colon cancer patients treated with adjuvant chemotherapy: The PROVENC3 study
CANCER RESEARCH
IF16.6
2024-03-220
PRE
Alarcon, Carmen Rubio; Georgiadis, Andrew; Franken, Ingrid A.; Wang, Haoyue; van Nassau, Sietske C.; Schraa, Suzanna J.; van der Kruijssen, Dave E.; van Rooijen, Karlijn; Linders, Theodora C.; Delis-van Diemen, Pien; Alkemade, Maartje; Bolijn, Anne; Tijssen, Marianne; Lemmens, Margriet; Meiqari, Lana; Ketelaars, Steven L.; Mosquera, Adria Closa; van Dongen, Miranda M.; Lanfermeijer, Mirthe; Lissenberg-Witte, Birgit I.; Bosch, Linda J.; Bisschop-Snetselaar, Teunise; Adriaans, Bregje; Greer, Amy; Riley, David; White, James R.; Greco, Christopher; Cox, Liam; Fox, Jesse; Victor, Kaitlin; Leech, Catherine; Angiuoli, Samuel V.; Kok, Niels F.; Punt, Cornelis J.; van den Broek, Daan; Koopman, Miriam; Meijer, Gerrit A.; Velculescu, Victor E.; Roodhart, Jeanine M.; Coupe, Veerle M.; Sausen, Mark; Vink, Geraldine R.; Fijneman, Remond J.
MEDOCC-CrEATE trial: Feasibility of measuring circulating tumor DNA after surgery to guide adjuvant chemotherapy in stage II colon cancer patients
CANCER RESEARCH
IF16.6
2024-03-220
PRE
Franken, Ingrid; Schraa, Suzanna; van Rooijen, Karlijn; van der Kruijssen, Dave; Rubio-Alarcon, Carmen; Ketelaars, Steven; van Nassau, Sietske; Snetselaar, Teunise; Adriaans, Bregje; Phallen, Jillian; Angiuoli, Sam; Greer, Amy; Verner, Ellen; Coupe, Veerle; Verkooijen, Helena; van Dongen, Miranda; Bosch, Linda; Lanfermeijer, Mirthe; van den Broek, Daan; Meijer, Gerrit; Velculescu, Victor; Sausen, Mark; Koopman, Miriam; Fijneman, Remond; Vink, Geraldine
External Quality Assessment on Molecular Tumor Profiling with Circulating Tumor DNA-Based Methodologies Routinely Used in Clinical Pathology within the COIN Consortium
CLINICAL CHEMISTRY
IF6.3
2024-03-140
OA
van der Leest, Paul; Rozendal, Pim; Hinrichs, John; van Noesel, Carel J. M.; Zwaenepoel, Karen; Deiman, Birgit; Huijsmans, Cornelis J. J.; van Eijk, Ronald; Speel, Ernst Jan M.; van Haastert, Rick J.; Ligtenberg, Marjolijn J. L.; van Schaik, Ron H. N.; Jansen, Maurice P. H. M.; Dubbink, Hendrikus J.; de Leng, Wendy W.; Leers, Mathie P. G.; Tamminga, Menno; van den Broek, Daan; van Kempen, Leon C.; Schuuring, Ed
A phase 2 trial combining afatinib with cetuximab in patients with EGFR exon 20 insertion-positive non-small cell lung cancer

阿法替尼联合西妥昔单抗治疗EGFR外显子20插入阳性非小细胞肺癌的2期临床试验

CANCER
IF5.1
2023-10-312
OAAI
van Veggel, Bianca A. M. H.; van der Wekken, Anthonie J.; Paats, Marthe S.; Hendriks, Lizza E. L.; Hashemi, Sayed M. S.; Daletzakis, Antonios; van den Broek, Daan; Bosch, Linda J. W.; Monkhorst, Kim; Smit, Egbert F.; de Langen, Adrianus J.

研究方向

暂未获取到该数据
G
Gerrit A. Meijer
H 指数:89论文数:1,107被引数:3.4万
R
Remond J.A. Fijneman
H 指数:45论文数:319被引数:9,778
G
Geraldine R. Vink
H 指数:25论文数:179被引数:3,420
K
Kim Monkhorst
H 指数:41论文数:391被引数:7,478
V
Veerle M.H. Coupé
H 指数:43论文数:365被引数:6,244
D
Daan C.L. Vessies
H 指数:7论文数:28被引数:288
T
Theodora C. Linders
H 指数:9论文数:25被引数:559
C
Cornelis J.A. Punt
H 指数:97论文数:706被引数:5.1万
M
Miriam Koopman
H 指数:57论文数:448被引数:1.6万
M
Mirthe Lanfermeijer
H 指数:9论文数:30被引数:278